TheraPsil
Highest Rated Comments
TheraPsil10 karma
TheraPsil currently supports patients who are suffering from end-of-life distress and cancer-related anxiety. We do however see the need for all Canadians in medical need to have access to this treatment option, including those suffering from treatment-resistant depression, PTSD, Cluster headaches, substance use disorders, etc. If you or a loved one are looking for support in accessing legal psilocybin therapy, please contact us on our website here: https://therapsil.ca/patients/
TheraPsil9 karma
We may have volunteer opportunities coming up soon! Follow us on our social channels and we’ll put out calls for volunteers on there. Thanks so much, it’s great to hear your support!
TheraPsil7 karma
Hi there, no free samples - sorry! We don't supply mushrooms - just advocate for folks to have legal access to them for medical purposes. We are working towards legalization for all in medical need.
TheraPsil4 karma
"Section 56 exemptions have served many people over the past year, however, we are now at a point where some patients are waiting over 130 days for a response to their section 56 exemptions.
Just like with medical cannabis, eventually, section 56 exemptions were deemed inefficient and arbitrary, and the courts forced regulations to be made.
I do believe we are at this point in Canada. Patients are wondering why they are being discriminated against - why their peers get psilocybin, but they don’t. And while the courts could be the ones to force the regulations, we at TheraPsil believe it is wrong for Patty Hajdu, our federally elected health minister, to push the decision to the courts.
We believe that the government needs to make a decision and help the patients who need access.
Over the summer we will be launching our largest media campaign yet in an effort to save Canadians with Cancer, PTSD, Depression, Addiction, etc.. from having to go to court.
We hope you will help! We will have much more information soon."
- Spencer Hawkswell, CEO, TheraPsil
TheraPsil16 karma
There is certainly a move by many companies to profit off the shift in policy around psilocybin. People see the value of psilocybin for helping patients and wherever there is potential value, there is money. Compounds and technologies that are being patented are partially driving the innovation. If someone finds a breakthrough compound, it may well be because of investment in something patentable. We are very lucky though because, just like cannabis, psilocybin mushrooms are non-patentable and are very inexpensive. However, this is part of the reason that it’s not yet a drug in Canada, because you would need millions to bring it through clinical trials, and at the end of the day, if you’re not able to profit off an investment, an investment is not made. As for the ethics of companies, I have not seen anything done by any companies that I would deem unethical. Many of these companies are made up of highly ethical clinicians and it’s not necessarily unethical to file a patent - sometimes it must be done when the risk and investment are great.
As a non-profit, patient-first organization, however, we are always listening to those who may be impacted by potential barriers to safe and equitable treatment. We are dedicated to fighting for Canadians in medical need of psilocybin therapy, and amplifying their voices to ensure their needs are heard and met." - Spencer Hawkswell, CEO, TheraPsil
View HistoryShare Link